CINXE.COM

<!DOCTYPE html><html lang="en-US"><head><title>Just a moment...</title><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="robots" content="noindex,nofollow"><meta name="viewport" content="width=device-width,initial-scale=1"><style>*{box-sizing:border-box;margin:0;padding:0}html{line-height:1.15;-webkit-text-size-adjust:100%;color:#313131;font-family:system-ui,-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Helvetica Neue,Arial,Noto Sans,sans-serif,Apple Color Emoji,Segoe UI Emoji,Segoe UI Symbol,Noto Color Emoji}body{display:flex;flex-direction:column;height:100vh;min-height:100vh}.main-content{margin:8rem auto;max-width:60rem;padding-left:1.5rem}@media (width <= 720px){.main-content{margin-top:4rem}}.h2{font-size:1.5rem;font-weight:500;line-height:2.25rem}@media (width <= 720px){.h2{font-size:1.25rem;line-height:1.5rem}}#challenge-error-text{background-image:url(data:image/svg+xml;base64,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);background-repeat:no-repeat;background-size:contain;padding-left:34px}@media (prefers-color-scheme:dark){body{background-color:#222;color:#d9d9d9}}</style><meta http-equiv="refresh" content="390"></head><body class="no-js"><div class="main-wrapper" role="main"><div class="main-content"><noscript><div class="h2"><span id="challenge-error-text">Enable JavaScript and cookies to continue</span></div></noscript></div></div><script>(function(){window._cf_chl_opt={cvId: '3',cZone: "www.fiercepharma.com",cType: 'managed',cRay: '8ead1bf998b55f9f',cH: 'bFThw0FSz61YV40PTMVPA5ecEb_JfLHIXyGusBKix38-1732993529-1.2.1.1-sx0N4kAKKkxSFxkoRHy0iC.T0jXrCrz8hkjv9q5GTSzUtb3tc0qJYOrquVSmwdKj',cUPMDTk: "\/marketing\/pharma-reputation-hits-high-americans-two-thirds-now-give-positive-rating-harris-poll?__cf_chl_tk=4gzlcogquJ8kR95Y1TULKoRKlZxzSJKjnRtGE4tel_w-1732993529-1.0.1.1-9e.KsV6bhnD1JAMmIcalnR8eUBPg0wZ4lz5WYP9rh.w",cFPWv: 'b',cITimeS: '1732993529',cTTimeMs: '1000',cMTimeMs: '390000',cTplC: 0,cTplV: 5,cTplB: 'cf',cK: "",fa: "\/marketing\/pharma-reputation-hits-high-americans-two-thirds-now-give-positive-rating-harris-poll?__cf_chl_f_tk=4gzlcogquJ8kR95Y1TULKoRKlZxzSJKjnRtGE4tel_w-1732993529-1.0.1.1-9e.KsV6bhnD1JAMmIcalnR8eUBPg0wZ4lz5WYP9rh.w",md: "evT5XouzrqHrEVDaEV.LdJvKMEFDL6OaBGGI0747DqU-1732993529-1.2.1.1-byQxG1NJpn4B21Ed6uC7Cv4T_fLRgE_Ysa3N87xs7JtIxpuALS.h5TKYk.Hpn0ntnnVifD2KshO_HLiNUU6iPvYwGZ3HVsaAgzxjeA86e7o5Vl35n_b01rEif2FzT56TxtwO9phy.itMXSNy7YnbRBQD6olrOGoUqa5GnBoBtCYSYfBYQu3ZEqdf4_TIeIl0yZbFvl3dwfmFxaVqlG5fYjT1iP_BDD3qMcgQnwdKngiJyBTVOzPMkA3aD6E_.gk8z5SapLgNCEvNHv_m.iBp9bVrxq_.NqBALVPRZWmHTFMunXu0VGwpFn8k8cS0q4yoU0_23ilikZ5rkO6jCzg3.Pm.OTKq48rExR6oO2RBNLd7xpXPpoTNAl3cJvhGcUsooN.rpzyoWcYvE3fqChiqMH3VO4fZaDFwucfykg3lOot3EXlYhxwrY9fixa9Qd9cb925UXYILx3t4nL645VfnMtb3matHgaO1YfmH.b0Kcr8xxxYu0Fu1.0W94sx9YXKucNzFTgJsk8FaA3FJA1xXsBaRQ4gg9qYfqo7v5NxUQ59rh3ynSPlhq07EzREanKE70wwU694SR7fTjUU9ogZzJx0spQQXFBugQyX_EHUND7ckD070N69u0yghcTYAU7EJzpcNB0efZDjkdd7e4oJtsL_g_nEefo8piuBwAao3i404.300o.qck.q8ylEMI6E5BR1gdsiZTpSRUARPM8uHVKEvZIjLNAq40FNM1PzfNzz8H.yIEqp6wGDRSx.VbrPXIrx8MO1RLb8lV4VPqfDu00l3b_xOlQq3V7UKYtfhOBpPdJlmMMeYxfohm8ts2xoJyb6O6WJP09vX6mt.VeKKJ0ahCH790u.VWOlleaZrAz0fXNdgezn1ngSzNYzzDEZp2aTx7UGRbCWhbvRfw2eMIIbssqgpePzAHB6CEezH.aEjUurbO.m1pqaw5idO32HhyQ4CQSrI6NmEuam0Qyo82I.suOMmXEd6zlnjib5t387spJrU0jzdVtwXeGrLaCDxhG7vFsLszi_GUHG8NWOFvtbpTdN2QVAwhZz3W3DeMpTnwGAdn8ZEAF3tXiofbCmpFOhabsQ9CX.jGCnFhEDxtm9EiNNLbQ7moyCF144g6g._Df4W436LV_PnmSZp6.Bqp9.v06VwUJAr6_orF9jROcm3bNhJTYan59zcXUAv40Bj87k3IoSLIiEXxcvpQsfOHDF3Z7152FrF9UtNFf488fkjfDtx83Ut5200bvEqhQ4mGsG.E0p1gQhrdgLlnI84DK8a5g.4Wscz3we6RID7tKZktRrloFLftx6ziPVAWI2wJwnFMmftrNFkiQ3Mn9Kx8xsE7TnYpTaUeuj31dCU3qqCB1SWF67e1k6gDP7IrvLIWfe9TRUS.vbzMCt9Fy7xiZkiDTU.z4502KhkeS2C8ZlrBjriGeMeNfKZ5evGok3gb3BEdydLOu.b3i98kM93Kgw1H8s.6bX68GXT5tm.e11kB0n.GVAYaZsarRUSRKIuqdqQS4VFzIXQjRxU91WKxwQaokkTU_Dj1H50Ile4dV0byAvCLLB5fRF2.vosin4Uifvjpd7sk6i4O8sYSL8kfxG0sxZLuHidOLOax_tC7oq8R3V7JP9deiGWoOOzQ6OIu8J4LtCmOGOzUH9aYZ6hjoYsAsyfujvaxD5EK6DGwX8cCe_OA4R06KBfkx22cP.RGGfM9FhY5iwbmd8TjulZAz9bQ3Mq4FVmFgz33udqHkUEPLxZcUtV1h27jjogWh0wKYEZeifajMT2bDx98uT5htpPeglWeelKGxiFhZMyC.En6jsd8wfsu94WNY1t1ZfK8UXLNazWXIFGH4Ml7B4awOvN6OCa.bYK8jUshfZC_kbg0psxj86V5c28w.ufbk9xXTa35FdGXwR_1fM3Ci1pGJqVUPKEMuLOpQXWWdkvvFItqrjI9pWkqGI4EsW.1ohHAOeFIpPf8D_UHoihCWr1kFKK3t5bJ5yJE56a90ZjnpEpe3fdtxDCjUeT2B6keqRJ8tsrMsT.YEjUHBp1caBc3.XWrUMyU4PBn8jAm7FggGGaT0zV4ctTqXLH4KKvpwcEsQCCYpUtCQd7OupvtMdg7EOd3mkUYExXnhpQod.slHgoSwvA2IFKVMSeVotCISMZ1FWZDpdLMc4SBOplAg9ATQedLWyFk9Z8DXAi8gCFOIShD9ZzFtSGnyetfo.fq4nMpkfH8pO3KCSpQarA7efGh70YU09yQ3PsGn.etRGlRt0_s8VzU2U7wRgZEFb9L8heSgGtq5SnEPd7MnAgahXGi_Hw4_PMCXZj728Vrz8CEGi8iwm5osE.Z9az5h632c.dEmS6KGR.OCwvY98pwGEu09qLTFrWAg.7RpYhMA8tWVpQFfZZQA0.mtQgGYShVvH8BtfU033w2LNz2477d2Iv3rcLR7Z0_HrTrbxMuNflfi9kHXq14Qap.Rf5swhICMiBEaub7YkeN2anNjqw.G5zIkJFn5ClMeE274g9C4YSF8Ocbn.New0soCNkMoIyVatL1zzfKjQHFYPnJ4Narf6S05HNy3LNIXMPSvGifqqUbYeCH4HuurH5rkG1Xo5oNRoBAihUAAYwNdt1qWzxpVrC_RpKZ3CRkmc1cfPV98i6Y2CPL1gfjE_l1.3F8afxbpoSM5sEuSHy6ukwdw7e8NjMxgbfzg_q1NpeprKzNDuF63q9zUJ5KO47s_97bpxJ5n2Wh.bq5p2WXXzQ.bGDQ1bRbcwVo2MX2pWGq_JvcQxRvPhkhSPpCiob674ec3fdj9wmiKvnNRHkNS3rkgDs6owtnSi.X4Sto1ttPbFwL18HSYh7M89DbfPbsU5WhSr9FDoXvms6HW.7YlEpNp91nGWJJQDWzAqDyR4riq5chpT5UgLs8RwQo.JMC4FB9WCi_QnNkeUgMudfxqJLYIkH1tieqexQx1bi4OHoZ0AhPWx6DY6WfQS.L9jtrs8qsa1SLxrXOfnE7f0avKE7T9phArQBjnmtUQzeG5mgtrmcSm1H_w7cfwn3mbu5Wn8Fh.Q8CSpQsJy1eV7d0avwvnSjs.Sckw7r8Q7IGg9VAjeVqLnmLNttuL_s4NLcBDk82In1kLCbo1nLKEc83pwdhzg9nV7V",mdrd: "ZnFC54Nhy3E_4HJybO4ZbtiPSB6mh5BhNKszSLzOQc0-1732993529-1.2.1.1-Uy9oYYLcGwDGkYnE2ZmSv9CjJFinfZACpH5852Onb7zuU5Y7nX4Pcus9EXNax8EIO4qxop.4OUsn5VqyaChLiyRgB7TU4znMh1t1HkULtuJpp4wy50Ixvt80ysolrrW1aoo0JElfjZW9FV6jUhRrXPuUyJGfNjGe6vPPkaH.78a.5GhpVJtBrDpBuxqDcP_MMUwueqbKUYKkyyFZLa2ZIJYxiUHTh1AQZWQ06CREV5kCeNh7xzXzxfLZPT3kWVPMok928LcF2ObcuODtB6HyjTmfw.BCP0FRZ7.kRPYdjZTWKfhvHmxy_LKonKHB.sKZwCMOAEEvDonR33qvReyvRRAh5TaCAyDM4NinsgFv_iV1VuzzJHzLu5xlAveAZwff385rBAPQgYhsq2LflMoeU.xsrRt93F.VhyoXo.5IyAmAwD5OH61wuToN19e0gEY9Ku0mf7taojByvsftzl5q08yjZdwas8dgVJcZkb99JsBuz5y3O9So6PLDLdT.8trlBPxQV2D2yR.qEtxKOxYuJYpln9FBwV59lz4stDdpP8WFn.CfSQSSgZ6jTT8R_jE6XprKFN9rpFEhua06myyruwfQrOww3xM5vMMqepi3Xr8nCwOy6SkmX88JHDtcQLtsIyzA3BtbNuPPuavWp6RDz4uCJzjeM60uVgq0u07h1M_TGpm8tER65bl8Xd_oo8v9R8Z.ZJtVhCGmGXZ1UrjXYCmJqogS_ABp8aGUYkYV0Q.ry3laOLyNReBkV9fLUk4G6JpkQc.4LCbht3SWcgYWw003.nKYDEyQua..JUnaZsVkYwFFdGoLlnnSbXZ47EBLMiVduNtn.ZFdt2Xyn27.jUBEAGG_AW9atTwzNNXnV0Y4RABpLK_e1nJ44Ww6mO5hk_ZEWZ09KamroBotEoJqHMA6NI6BuvTGtPaQN9Qkj8ldVBikpECDbnLn_cUtjROEI5O4QvwlzBJg50slsiIKu.ZNNqpmQWdmxc2SKVG0lMJJ5B4p5_XwROEAOPQwDjS8xQ1rlRaJrKSPr1WcoA2zQqmNb.1l.xV5t17KDdLESzkMWJCzfUrPi4iTwwFkEX1qPCsm_AJe0DHgv4B5uFASJLVBpnjJNeDW0mEDIgZzGZsJqEeYE.1c1xR4UD92arAmvUxGAy.LgIBCjSDgaPKnMxrvSvlsQugruer21_xV55P0vNsRv_Q9QS3uBfSR8fSeT6bL2EjHuXaN_zCN5kgT4h9n_vlm8FoWrJ9f6l7F8yL5oCQREgWO68b7D0nsYaRtdr8EE0NAwRVy0Ckyx8c_.BLxUn6tMwL5eiWVLpI9Kwe_X3BLuKvLpHvkEMWhDj.TXo6rzofy74MmS5NBHZwaY9xVOM8n5kXJU34OT7HvKuYVdSqLI9DczxHHl65vEomCw6HmKGJ19i.hE5cbtZ5jujRv0jHQJB54JN4lRDncRrHdcCzSSbmt4vu8IVm6fC3lPvu7OQMffTZVvlhgrcUZybT4miNyD1S14CDaIFG74YBr7KcgNFtmaAiowJ.1.U81NCjqJ_tLHpjs7SjRlMZLb0kD5Ws6ctR4tp7OBMfype0MNY2h6gY.0dXkrpbO.ABRCptrHrAhmcfjOeSrFHJ1fzJAAIqfbgGPvu.O.iuh3JxZNG4tOJlDQbpW9H3gtUc4Zy7yRlmrFEwTdqPQOCOF8r.TP0y6pvSqWBJr91UrX550cmFIOwHnv78WjM962lUovQwA5FFrxKsyOzFPD0blyOZwJiIb6RYEklk4FK9NdzczyXdmv6t43GNYwrzgaIp5f60xKMR3ej64IpJnsHPhWEKGwgwxypGLGbUDLS26HOw6IDjYdeZK.BOKH86T88aQ9pakHhQMGkJMgw5a0FvXGqRj2OYAQnVeJIeqnAGsbyAbyMTG.wYWizvCk4thDDetVilkwwwd2tpm4zSLvLRH553G5QOZHtdB5XDMTMgvot1zTNIsI7wZEbVXEELbXDFMo8IN0zjMAl8K4LokVs3E9g"};var cpo = document.createElement('script');cpo.src = '/cdn-cgi/challenge-platform/h/b/orchestrate/chl_page/v1?ray=8ead1bf998b55f9f';window._cf_chl_opt.cOgUHash = location.hash === '' && location.href.indexOf('#') !== -1 ? '#' : location.hash;window._cf_chl_opt.cOgUQuery = location.search === '' && location.href.slice(0, location.href.length - window._cf_chl_opt.cOgUHash.length).indexOf('?') !== -1 ? '?' : location.search;if (window.history && window.history.replaceState) {var ogU = location.pathname + window._cf_chl_opt.cOgUQuery + window._cf_chl_opt.cOgUHash;history.replaceState(null, null, "\/marketing\/pharma-reputation-hits-high-americans-two-thirds-now-give-positive-rating-harris-poll?__cf_chl_rt_tk=4gzlcogquJ8kR95Y1TULKoRKlZxzSJKjnRtGE4tel_w-1732993529-1.0.1.1-9e.KsV6bhnD1JAMmIcalnR8eUBPg0wZ4lz5WYP9rh.w" + window._cf_chl_opt.cOgUHash);cpo.onload = function() {history.replaceState(null, null, ogU);}}document.getElementsByTagName('head')[0].appendChild(cpo);}());</script></body></html>